Annual SGA
$62.58 M
+$3.04 M+5.11%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual SGA is $62.58 million, with the most recent change of +$3.04 million (+5.11%) on December 31, 2023.
- During the last 3 years, STRO annual SGA has risen by +$25.77 million (+69.98%).
- STRO annual SGA is now at all-time high.
Performance
STRO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$14.33 M
+$1.96 M+15.84%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly SGA is $14.33 million, with the most recent change of +$1.96 million (+15.84%) on September 30, 2024.
- Over the past year, STRO quarterly SGA has dropped by -$2.47 million (-14.72%).
- STRO quarterly SGA is now -14.72% below its all-time high of $16.80 million, reached on December 31, 2023.
Performance
STRO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.56 B
-$123.95 M-5.09%
September 30, 2024
Summary
- As of February 7, 2025, STRO TTM SGA is -$2.56 billion, with the most recent change of -$123.95 million (-5.09%) on September 30, 2024.
- Over the past year, STRO TTM SGA has dropped by -$2.62 billion (-4185.86%).
- STRO TTM SGA is now -2123.35% below its all-time high of -$115.01 million.
Performance
STRO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
STRO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.1% | -14.7% | -4185.9% |
| 3 y3 years | +70.0% | -14.7% | -4185.9% |
| 5 y5 years | +192.7% | -14.7% | -4185.9% |
STRO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.8% | -14.7% | +15.8% | -122.1% | at low |
| 5 y | 5-year | at high | +92.0% | -14.7% | +65.8% | -265.8% | at low |
| alltime | all time | at high | +322.4% | -14.7% | +254.6% | -2123.3% | at low |
Sutro Biopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $14.33 M(+15.8%) | $56.23 M(-1.6%) |
| Jun 2024 | - | $12.37 M(-2.8%) | $57.16 M(-4.4%) |
| Mar 2024 | - | $12.72 M(-24.3%) | $59.79 M(-4.5%) |
| Dec 2023 | $62.58 M(+5.1%) | $16.80 M(+10.1%) | $62.58 M(+3.4%) |
| Sep 2023 | - | $15.27 M(+1.8%) | $60.50 M(+1.0%) |
| Jun 2023 | - | $15.00 M(-3.3%) | $59.87 M(-0.2%) |
| Mar 2023 | - | $15.51 M(+5.4%) | $60.02 M(+0.8%) |
| Dec 2022 | $59.54 M(+6.3%) | $14.72 M(+0.5%) | $59.54 M(-1.7%) |
| Sep 2022 | - | $14.64 M(-3.3%) | $60.59 M(-3.1%) |
| Jun 2022 | - | $15.14 M(+0.7%) | $62.53 M(+4.3%) |
| Mar 2022 | - | $15.04 M(-4.6%) | $59.94 M(+7.0%) |
| Dec 2021 | $56.00 M(+52.1%) | $15.76 M(-5.0%) | $56.00 M(+10.6%) |
| Sep 2021 | - | $16.59 M(+32.2%) | $50.62 M(+17.4%) |
| Jun 2021 | - | $12.54 M(+12.9%) | $43.11 M(+10.0%) |
| Mar 2021 | - | $11.11 M(+7.0%) | $39.21 M(+6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $36.82 M(+13.0%) | $10.38 M(+14.4%) | $36.82 M(+4.8%) |
| Sep 2020 | - | $9.08 M(+5.0%) | $35.13 M(+2.8%) |
| Jun 2020 | - | $8.64 M(-0.8%) | $34.17 M(+1.7%) |
| Mar 2020 | - | $8.71 M(+0.2%) | $33.59 M(+3.1%) |
| Dec 2019 | $32.59 M(+52.4%) | $8.70 M(+7.1%) | $32.59 M(+3.6%) |
| Sep 2019 | - | $8.12 M(+0.6%) | $31.47 M(+9.6%) |
| Jun 2019 | - | $8.07 M(+4.6%) | $28.71 M(+16.3%) |
| Mar 2019 | - | $7.71 M(+1.9%) | $24.68 M(+15.4%) |
| Dec 2018 | $21.38 M(+30.6%) | $7.57 M(+41.5%) | $21.38 M(+19.6%) |
| Sep 2018 | - | $5.35 M(+32.4%) | $17.87 M(+2.6%) |
| Jun 2018 | - | $4.04 M(-8.5%) | $17.42 M(+30.2%) |
| Mar 2018 | - | $4.41 M(+8.5%) | $13.38 M(+49.2%) |
| Dec 2017 | $16.37 M(+10.5%) | $4.07 M(-16.9%) | $8.96 M(+83.1%) |
| Sep 2017 | - | $4.89 M | $4.89 M |
| Dec 2016 | $14.82 M | - | - |
FAQ
- What is Sutro Biopharma annual SGA?
- What is the all time high annual SGA for Sutro Biopharma?
- What is Sutro Biopharma annual SGA year-on-year change?
- What is Sutro Biopharma quarterly SGA?
- What is the all time high quarterly SGA for Sutro Biopharma?
- What is Sutro Biopharma quarterly SGA year-on-year change?
- What is Sutro Biopharma TTM SGA?
- What is the all time high TTM SGA for Sutro Biopharma?
- What is Sutro Biopharma TTM SGA year-on-year change?
What is Sutro Biopharma annual SGA?
The current annual SGA of STRO is $62.58 M
What is the all time high annual SGA for Sutro Biopharma?
Sutro Biopharma all-time high annual SGA is $62.58 M
What is Sutro Biopharma annual SGA year-on-year change?
Over the past year, STRO annual SGA has changed by +$3.04 M (+5.11%)
What is Sutro Biopharma quarterly SGA?
The current quarterly SGA of STRO is $14.33 M
What is the all time high quarterly SGA for Sutro Biopharma?
Sutro Biopharma all-time high quarterly SGA is $16.80 M
What is Sutro Biopharma quarterly SGA year-on-year change?
Over the past year, STRO quarterly SGA has changed by -$2.47 M (-14.72%)
What is Sutro Biopharma TTM SGA?
The current TTM SGA of STRO is -$2.56 B
What is the all time high TTM SGA for Sutro Biopharma?
Sutro Biopharma all-time high TTM SGA is -$115.01 M
What is Sutro Biopharma TTM SGA year-on-year change?
Over the past year, STRO TTM SGA has changed by -$2.62 B (-4185.86%)